[A13-30] Addendum to Commission A13-16 (vildagliptin)
Last updated 01.10.2013
Project no.:
A13-30
Commission:
Commission awarded on 07.08.2013 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Digestion, metabolism and hormones
Note:
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment
Accompanying information| Project no. | Title | Status |
|---|---|---|
| A13-16 | Vildagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |
Federal Joint Committee (G-BA)
2013-10-01 A G-BA decision was published.